IS7310A - 3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar - Google Patents

3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar

Info

Publication number
IS7310A
IS7310A IS7310A IS7310A IS7310A IS 7310 A IS7310 A IS 7310A IS 7310 A IS7310 A IS 7310A IS 7310 A IS7310 A IS 7310A IS 7310 A IS7310 A IS 7310A
Authority
IS
Iceland
Prior art keywords
tafia
imidazolyl
inhibit
alkoxypropanoic
acids
Prior art date
Application number
IS7310A
Other languages
English (en)
Icelandic (is)
Inventor
Moira Norfor Allerton Charlotte
John Bull David
Edward Bunnage Mark
Sandwich
John Maguire Robert
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0201389A external-priority patent/GB0201389D0/en
Priority claimed from GB0202027A external-priority patent/GB0202027D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS7310A publication Critical patent/IS7310A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS7310A 2002-01-22 2004-06-14 3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar IS7310A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0201389A GB0201389D0 (en) 2002-01-22 2002-01-22 3-(imidazolyl)-2-alkoxypropanoic acids
GB0202027A GB0202027D0 (en) 2002-01-29 2002-01-29 3-(imidazolyl)-2-alkoxypropanoic acids
PCT/IB2003/000060 WO2003061652A1 (en) 2002-01-22 2003-01-10 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors

Publications (1)

Publication Number Publication Date
IS7310A true IS7310A (is) 2004-06-14

Family

ID=27614792

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7310A IS7310A (is) 2002-01-22 2004-06-14 3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar

Country Status (24)

Country Link
EP (1) EP1467731A1 (zh)
JP (1) JP2005520811A (zh)
KR (1) KR20040077775A (zh)
CN (1) CN1620291A (zh)
AP (1) AP2004003084A0 (zh)
AR (1) AR038197A1 (zh)
BR (1) BR0307016A (zh)
CA (1) CA2472238A1 (zh)
EA (1) EA200400716A1 (zh)
EC (1) ECSP045200A (zh)
HR (1) HRP20040659A2 (zh)
IL (1) IL162677A0 (zh)
IS (1) IS7310A (zh)
MA (1) MA27167A1 (zh)
MX (1) MXPA04006573A (zh)
NO (1) NO20043457L (zh)
OA (1) OA12756A (zh)
PA (1) PA8563501A1 (zh)
PE (1) PE20030929A1 (zh)
PL (1) PL371487A1 (zh)
TN (1) TNSN04121A1 (zh)
TW (1) TW200302094A (zh)
UY (1) UY27615A1 (zh)
WO (1) WO2003061652A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005051384A1 (en) * 2003-11-25 2005-06-09 Pfizer Limited Stabilised pharmaceutical compositions
US20060234986A1 (en) * 2005-04-18 2006-10-19 Schering Aktiengesellschaft Use of TAFI inhibitors for enhanced myocardial reperfusion and facilitated PCI
EP2361910A4 (en) 2008-10-29 2012-08-01 Taisho Pharmaceutical Co Ltd CONNECTION WITH TAFIA-INHIBITOR EFFECT
EP2373634B1 (en) * 2008-12-05 2015-11-11 Mochida Pharmaceutical Co., Ltd. Morpholinone compounds as factor ixa inhibitors
US8987242B2 (en) 2008-12-05 2015-03-24 Merck Sharp & Dohme Corp. Morpholinone compounds as factor IXA inhibitors
CA2793523C (en) 2010-03-18 2015-05-05 Daiichi Sankyo Company, Limited Cyclopropanecarboxylic acid derivative
BR112012017474A2 (pt) * 2010-03-18 2016-04-19 Daiichi Sankyo Co Ltd composto, sal farmacologicamente aceitável do composto, droga farmacêutica, inibidor da fibrinólise ativável por trombina, promotor da fibrinólise, droga preventiva ou terapêutica, composição farmacêutica, uso de uma composição farmacêutica, inibidor de tafia para injeção, e, uso de uma composição farmacêutica
US9834527B2 (en) 2013-06-10 2017-12-05 Sanofi Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals
US20190117624A1 (en) 2016-03-29 2019-04-25 Daiichi Sankyo Company, Limited Therapeutic agent for inflammatory bowel diseases
AU2018333913B2 (en) 2017-09-14 2022-11-17 Daiichi Sankyo Company, Limited Compound having cyclic structure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901572D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
KR20030022412A (ko) * 2000-08-17 2003-03-15 화이자 인코포레이티드 ＴＡＦＩａ 억제제인 치환된 이미다졸

Also Published As

Publication number Publication date
KR20040077775A (ko) 2004-09-06
EA200400716A1 (ru) 2004-12-30
ECSP045200A (es) 2004-08-27
OA12756A (en) 2006-07-03
CN1620291A (zh) 2005-05-25
TW200302094A (en) 2003-08-01
WO2003061652A8 (en) 2004-09-10
AR038197A1 (es) 2005-01-05
AP2004003084A0 (en) 2004-09-30
MA27167A1 (fr) 2005-01-03
IL162677A0 (en) 2005-11-20
BR0307016A (pt) 2004-11-03
TNSN04121A1 (en) 2006-06-01
CA2472238A1 (en) 2003-07-31
JP2005520811A (ja) 2005-07-14
PA8563501A1 (es) 2004-08-31
HRP20040659A2 (en) 2004-10-31
EP1467731A1 (en) 2004-10-20
NO20043457L (no) 2004-08-19
PE20030929A1 (es) 2003-11-05
WO2003061652A1 (en) 2003-07-31
MXPA04006573A (es) 2004-10-04
PL371487A1 (en) 2005-06-13
UY27615A1 (es) 2003-08-29

Similar Documents

Publication Publication Date Title
MA28630B1 (fr) Inhibiteurs d'iap
DE50309032D1 (de) Fungizide wirkstoffkombinationen
NO20055742D0 (no) Gjenget forbindelse for stalror
DE50309693D1 (de) Fungizide wirkstoffkombination
DK1358165T3 (da) Imidazolderivater
DK1311488T3 (da) Substituerede imidazoler som tafia-inhibitorer
IS7310A (is) 3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar
ITMI20042462A1 (it) Memoria ausiliare
FIU20020151U0 (fi) Laatikko
ATA13662003A (de) Schirmartiger wäschetrockner
ATE427945T1 (de) Imidazolderivate
ITBO20040325A1 (it) Dispositivo per l'avvitamento di tappi su corrispondenti articoli
ATA13652003A (de) Schirmartiger wäschetrockner
DE602004002369D1 (de) Sicherungsmutter
ZA200405344B (en) 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors.
DE10393292D2 (de) Holzmantel
GB0202027D0 (en) 3-(imidazolyl)-2-alkoxypropanoic acids
NO20033080D0 (no) Reguleringssele
AT503243A3 (de) Sockelleiste
DE60230770D1 (de) Verbesserte Speicheranordnung
GB0201387D0 (en) 3-(imidazolyl)-2-aminopropanoic acids
GB0201911D0 (en) 3-(Imidazolyl)-2-Aminopropanoic acids
ITPA20020004A1 (it) Scatola di connessione
UA6390S (uk) Автобус малий 2-го класу
DE502004007434D1 (de) Streichvorrichtung